-
The discussion revolved around the status of the indigenous vaccine and the plans to make it available in India and rest of the world
-
The rates for samples collected from home for RT-PCR testing have also been reduced from Rs. 1,200 to Rs. 750
-
This new variant has been identified as a set of multiple changes and mutations in the ‘Spike’ protein which the SARS-CoV 2 uses to infect human cells
-
It also said that protective level of antibodies generally develop two weeks after receiving the second dose.
-
The number of people who have recuperated from the disease surged to 95,20,827 pushing the national recovery rate to 95.40 per cent.
-
There are 3,22,366 active coronavirus infections in the country which comprises 3.24 per cent of the total caseload.
-
The test is a rapid point-of-care nasopharyngeal swab test that directly detects the presence or absence of coronavirus antigen in the patient's body, generating results within 15-20 minutes.
-
There are 3,32,002 active coronavirus infections in the country which constitute 3.34 per cent of the total caseload.
-
There are 3,39,820 active coronavirus infections in the country which constitute 3.43 per cent of the total caseload.
-
There are 3,78,909 active coronavirus infections in the country now which comprises 3.89 per cent of the total caseload.
-
The number of people who have recuperated from the disease surged to 91,78,946, pushing the national recovery rate to 94.59 per cent.
-
The dry swab method is a modification of the RT-PCR test by cutting down a few steps.
-
The number of people who have recuperated from the disease surged to 91,00,792 pushing the national recovery rate to 94.37 per cent.
-
Bharat Biotech stated it is an innovator, vaccine developer and manufacturer and safety of vaccines is its primary objective, followed by efficacy
-
The 67-year-old minister was given the first shot on November 20.
-
The 67-year-old is a senior leader of the ruling Bharatiya Janata Party (BJP) and a legislator from Ambala Cantt assembly constituency.
-
The number of people who have recuperated from the disease surged to 90,16,289 pushing the national recovery rate to 94.20 per cent.
-
The number of people who have recuperated from the disease surged to 89,73,373 pushing the national recovery rate to 94.11 per cent.
-
The number of people who have recuperated from the disease surged to 89,32,647 pushing the national recovery rate to 94.03 per cent.
-
Takes stock of the progress made by the Hyderabad-based company in the trials of Covaxin, jointly developed with ICMR-National Institute of Virology